Calidi Biotherapeutics Files 8-K with Material Agreements
Ticker: CLDWW · Form: 8-K · Filed: Jul 10, 2025 · CIK: 1855485
| Field | Detail |
|---|---|
| Company | Calidi Biotherapeutics, Inc. (CLDWW) |
| Form Type | 8-K |
| Filed Date | Jul 10, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, equity-sale, disclosure
TL;DR
Calidi Biotherapeutics signed a material agreement and sold equity on July 9th.
AI Summary
On July 9, 2025, Calidi Biotherapeutics, Inc. entered into a material definitive agreement. The company also disclosed unregistered sales of equity securities and provided a Regulation FD disclosure. The filing includes financial statements and exhibits.
Why It Matters
This 8-K filing indicates significant corporate activity, including new agreements and potential equity issuances, which could impact the company's financial structure and future operations.
Risk Assessment
Risk Level: medium — The filing mentions material definitive agreements and unregistered sales of equity, which can introduce financial and operational risks.
Key Players & Entities
- Calidi Biotherapeutics, Inc. (company) — Registrant
- July 9, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 001-40789 (identifier) — Commission File Number
- 86-2967193 (identifier) — I.R.S. Employer Identification No.
- 4475 Executive Dr., Suite 200, San Diego, CA 92121 (address) — Address of principal executive offices
FAQ
What type of material definitive agreement did Calidi Biotherapeutics enter into?
The filing does not specify the exact nature of the material definitive agreement, only that one was entered into on July 9, 2025.
What was the date of the earliest event reported in this 8-K filing?
The earliest event reported was on July 9, 2025.
What are the principal executive offices of Calidi Biotherapeutics, Inc.?
The principal executive offices are located at 4475 Executive Dr., Suite 200, San Diego, CA 92121.
What is the Commission File Number for Calidi Biotherapeutics, Inc.?
The Commission File Number is 001-40789.
What is the I.R.S. Employer Identification Number for Calidi Biotherapeutics, Inc.?
The I.R.S. Employer Identification Number is 86-2967193.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 10, 2025 regarding Calidi Biotherapeutics, Inc. (CLDWW).